Works matching IS 10870156 AND DT 2008 AND VI 26 AND IP 1
Results: 36
The regulator disapproves.
- Published in:
- 2008
- Publication type:
- Editorial
News in brief.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 11, doi. 10.1038/nbt0108-11
- By:
- Publication type:
- Article
Greg Simon.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 13, doi. 10.1038/nbt0108-13
- By:
- Publication type:
- Article
Executive compensation at private biotech companies: a competitive environment.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 133, doi. 10.1038/nbt0108-133
- By:
- Publication type:
- Article
People.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 136, doi. 10.1038/nbt0108-136
- Publication type:
- Article
Wage power in the life sciences.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 14, doi. 10.1038/nbt0108-14
- By:
- Publication type:
- Article
Biotech as Bush bows out.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 15, doi. 10.1038/nbt0108-15
- By:
- Publication type:
- Article
Shareholders flex their muscles.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 19, doi. 10.1038/nbt0108-19
- By:
- Publication type:
- Article
We speak for small biotech.
- Published in:
- 2008
- By:
- Publication type:
- Letter
We speak for small biotech.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Where did the scientific method go?
- Published in:
- 2008
- By:
- Publication type:
- Letter
Response to Where did the scientific method go?
- Published in:
- 2008
- Publication type:
- Letter
Ethics of research on human biological materials.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Merck's HIV vaccine flop brings vectors under closer scrutiny.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 3, doi. 10.1038/nbt0108-3
- By:
- Publication type:
- Article
Privatizing biomedical research—a 'third way'.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 31, doi. 10.1038/nbt0108-31
- By:
- Publication type:
- Article
Chinese health biotech and the billion-patient market.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 37, doi. 10.1038/nbt0108-37
- By:
- Publication type:
- Article
Fractured European market undermines biosimilar launches.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 5, doi. 10.1038/nbt0108-5
- By:
- Publication type:
- Article
Reach-through claims for drug target patents: Rx for pharmaceutical policy.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 55, doi. 10.1038/nbt0108-55
- By:
- Publication type:
- Article
Recent patent applications in antibodies.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 57, doi. 10.1038/nbt0108-57
- Publication type:
- Article
Simpler and safer cell reprogramming.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 59, doi. 10.1038/nbt0108-59
- By:
- Publication type:
- Article
Illuminating the switch in influenza viruses.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 60, doi. 10.1038/nbt0108-60
- By:
- Publication type:
- Article
Humanizing mouse thrombi.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 62, doi. 10.1038/nbt0108-62
- By:
- Publication type:
- Article
Primate therapeutic cloning in practice.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 64, doi. 10.1038/nbt0108-64
- By:
- Publication type:
- Article
Genome resequencing and genetic variation.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 65, doi. 10.1038/nbt0108-65
- By:
- Publication type:
- Article
Research highlights.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 67, doi. 10.1038/nbt0108-67
- By:
- Publication type:
- Article
Protein-protein interaction networks and biology—what's the connection?
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 69, doi. 10.1038/nbt0108-69
- By:
- Publication type:
- Article
Government report critical of FDA blasted as misleading.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 7, doi. 10.1038/nbt0108-7
- By:
- Publication type:
- Article
Cellulosic ethanol booms despite unproven business models.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 8, doi. 10.1038/nbt0108-8
- By:
- Publication type:
- Article
Allergenicity assessment of genetically modified crops—what makes sense?
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 73, doi. 10.1038/nbt1343
- By:
- Publication type:
- Article
A quantitative analysis of kinase inhibitor selectivity.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 127, doi. 10.1038/nbt1358
- By:
- Publication type:
- Article
Microscale culture of human liver cells for drug development.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 120, doi. 10.1038/nbt1361
- By:
- Publication type:
- Article
Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 91, doi. 10.1038/nbt1366
- By:
- Publication type:
- Article
Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 114, doi. 10.1038/nbt1373
- By:
- Publication type:
- Article
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 101, doi. 10.1038/nbt1374
- By:
- Publication type:
- Article
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 83, doi. 10.1038/nbt1377
- By:
- Publication type:
- Article
Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 107, doi. 10.1038/nbt1375
- By:
- Publication type:
- Article